CAPLIPOINT.NS Cash Flow
Caplin Point Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:40
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹2.72 Bn | ₹3.11 Bn | ₹4.32 Bn | ₹5.23 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-2.18 Bn | ₹-3.13 Bn | ₹-3.35 Bn | ₹-5.82 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-0.28 Bn | ₹-0.38 Bn | ₹-0.38 Bn | ₹-0.46 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.01 Bn | ₹0.01 Bn | ₹0.00 Bn | ₹0.00 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹0.27 Bn | ₹-0.39 Bn | ₹0.59 Bn | ₹-1.05 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹1.51 Bn | ₹1.78 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from CAPLIPOINT.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).